Design Therapeutics (DSGN)
NASDAQ:DSGN
Want to see DSGN full AI Analyst Report?
DSGN Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DSGN Stock 12 Month Forecast
Average Price Target
$16.40
▲(83.45% Upside)
| Highest Price Target$20.00 | Average Price Target$16.40 | Lowest Price Target$14.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
$12→$20
Buy
123.71%
Upside
Reiterated
04/29/26
Craig-Hallum
$15
Buy
67.79%
Upside
Assigned
04/29/26
RBC Capital
$14
Buy
56.60%
Upside
Reiterated
04/28/26
Jefferies
$10.01→$15
Buy
67.79%
Upside
Initiated
03/15/26
Oppenheimer
$18
Buy
101.34%
Upside
Reiterated
03/10/26
Leerink Partners
$14
Buy
56.60%
Upside
Upgraded
12/03/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
$12→$20
Buy
123.71%
Upside
Reiterated
04/29/26
Craig-Hallum
$15
Buy
67.79%
Upside
Assigned
04/29/26
RBC Capital
$14
Buy
56.60%
Upside
Reiterated
04/28/26
Jefferies
$10.01→$15
Buy
67.79%
Upside
Initiated
03/15/26
Oppenheimer
$18
Buy
101.34%
Upside
Reiterated
03/10/26
Leerink Partners
$14
Buy
56.60%
Upside
Upgraded
12/03/25
Best Analysts Covering Design Therapeutics
3 Months
xxx
Success Rate
4/8 ratings generated profit
Average Return
+0.09%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.09% per trade.
1 Year
Success Rate
2/8 ratings generated profit
Average Return
-35.48%
Copying Leonid Timashev's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -35.48% per trade.
2 Years
xxx
Success Rate
2/6 ratings generated profit
Average Return
+62.02%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +62.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
DSGN Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
2
3
2
3
2
Buy
1
1
1
2
5
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
3
5
7
Each month's total comprises the sum of three months' worth of ratings.
DSGN Financial Forecast
DSGN Stock Forecast FAQ
What is DSGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Design Therapeutics’s 12-month average price target is 16.40.
What is DSGN’s upside potential, based on the analysts’ average price target?
Design Therapeutics has 83.45% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DSGN a Buy, Sell or Hold?
Design Therapeutics has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Design Therapeutics’s price target?
The average price target for Design Therapeutics is 16.40. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $14.00. The average price target represents 83.45% Increase from the current price of $8.94.
The highest analyst price target is $20.00 ,the lowest forecast is $14.00. The average price target represents 83.45% Increase from the current price of $8.94.
What do analysts say about Design Therapeutics?
Design Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of DSGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.